Company Filing History:
Years Active: 2012
Introduction
Yaoru Lu, a distinguished inventor based in Shanghai, China, has made significant strides in pharmaceutical innovations. He is recognized for his contributions to cardiovascular medicine, particularly through his pioneering patent, which aims to improve treatment options for patients suffering from cardiovascular diseases.
Latest Patents
Yaoru Lu holds one patent, which is a pharmaceutical composition designed for treating cardiovascular disease. This innovative formulation includes an active ingredient known as 2-butyl-4-chloro-1-[2'-(1H-tetrazol-5-yl)1,1′-biphenyl-methyl]imidazole-5-carboxylic acid, 1-[(isopropoxy)carbonyloxy]methyl ester, dispersed in pharmaceutically acceptable carriers. The composition is versatile and can be developed into various solid dosage forms such as powders, granules, dripping pills, micro-pellets, tablets, capsules, and lozenges. Additionally, it can be administered orally or through alternative methods like sublingual administration, enhancing its adaptability for different patient needs.
Career Highlights
Yaoru Lu is currently affiliated with Shanghai Allist Pharmaceutical, Inc., where he collaborates with fellow professionals to advance pharmaceutical solutions. His work has not only contributed to improving cardiovascular treatments but has also positioned him as a reputable figure in the pharmaceutical innovation landscape.
Collaborations
In his career, Yaoru Lu has worked alongside Jianhui Guo, highlighting the importance of teamwork in the journey of innovation. Their collaboration reflects a commitment to pushing boundaries in the development of effective medical compositions.
Conclusion
In summary, Yaoru Lu's contributions to the field of pharmaceuticals, particularly in developing new treatments for cardiovascular diseases, demonstrate his innovative spirit and dedication to improving healthcare. With his patent and ongoing work at Shanghai Allist Pharmaceutical, Inc., he is poised to make a significant impact on the medical community.